NCT06019455 The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
| NCT ID | NCT06019455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-06-01 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.
Eligibility Criteria
Inclusion Criteria: * Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer. * Planned to undergo definitive chemoradiotherapy ± immunotherapy; * Males or females aged 18 to 75; * Able to communicate with medical staff. Exclusion Criteria: Patients with cognitive impairments.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06019455 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06019455 currently recruiting?
Yes, NCT06019455 is actively recruiting participants. Contact the research team at qiubo@sysucc.org.cn for enrollment information.
Where is the NCT06019455 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06019455 clinical trial?
NCT06019455 is sponsored by Sun Yat-sen University. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.